Structural Biology in Cancer Research
Structural Biology in Cancer Research
The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modeling mainly aims at drug designing. Eventually, many researchers in Structural biology carry out cancer research to extend the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used which is defined as the response of immune system to reject cancer. Immunotherapies can be a better way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).
-
Antibody Therapy
-
Cellular Immunotherapy
-
Cytokine Therapy
-
Combinational Immunotherapy
Related Conference of Structural Biology in Cancer Research
Structural Biology in Cancer Research Conference Speakers
Recommended Sessions
- Computational Approaches in Structural Biology
- Structural Biology Complexity Arenas
- 3D Structure Determination
- Biomolecules
- Drug Designing
- Frontiers in Structural Biology
- Hybrid Approaches for Structure Prediction
- Molecular Modeling & Dynamics
- Recent Advances in Structural Biology
- Sequencing
- Signalling Biology
- Structural Bioinformatics and Proteomics
- Structural Biology and Single Molecules
- Structural Biology Databases
- Structural Biology in Cancer Research
- Structural Molecular Biology
- Structural Virology
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)